Encompass Health Corp (EHC) Shares Bought by First Trust Advisors LP

First Trust Advisors LP grew its position in shares of Encompass Health Corp (AMEX:EHC) by 456.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 467,729 shares of the company’s stock after buying an additional 383,656 shares during the period. First Trust Advisors LP owned about 0.48% of Encompass Health worth $36,459,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. IFP Advisors Inc lifted its holdings in shares of Encompass Health by 696.3% in the 3rd quarter. IFP Advisors Inc now owns 1,521 shares of the company’s stock worth $119,000 after purchasing an additional 1,330 shares during the last quarter. Harvest Fund Management Co. Ltd bought a new stake in shares of Encompass Health in the 2nd quarter worth approximately $107,000. Bridgeworth LLC bought a new stake in shares of Encompass Health in the 2nd quarter worth approximately $127,000. Meeder Asset Management Inc. lifted its holdings in shares of Encompass Health by 97.0% in the 2nd quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock worth $142,000 after purchasing an additional 1,030 shares during the last quarter. Finally, Rehmann Capital Advisory Group lifted its holdings in shares of Encompass Health by 108.3% in the 2nd quarter. Rehmann Capital Advisory Group now owns 2,233 shares of the company’s stock worth $151,000 after purchasing an additional 1,161 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors.

In related news, insider Andrew L. Price sold 9,457 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total value of $756,938.28. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by company insiders.

EHC opened at $57.67 on Friday. Encompass Health Corp has a 12 month low of $40.86 and a 12 month high of $59.29. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

Encompass Health (AMEX:EHC) last posted its earnings results on Monday, October 29th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.79 by $0.12. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Encompass Health’s quarterly revenue was up 8.8% on a year-over-year basis. On average, analysts anticipate that Encompass Health Corp will post 2.72 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Investors of record on Wednesday, January 2nd will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend is Monday, December 31st.

Several brokerages recently issued reports on EHC. Zacks Investment Research raised Encompass Health from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a report on Wednesday. SunTrust Banks reissued a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Friday, July 20th. Credit Suisse Group raised their price target on Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, July 26th. Mizuho reissued a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Thursday, July 26th. Finally, Piper Jaffray Companies raised Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $70.30.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

See Also: Beta

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply